Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 5, 2015, Pages 913-924

  Xia, Di ^a   Li, Chuanzhou ^a   Götz, Jürgen ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer's disease; Frontotemporal dementia; Fyn; Phosphorylation; PSD95; Tau

Indexed keywords

ALANINE; EPITOPE; GLUTAMIC ACID; PROTEIN KINASE FYN; TAU PROTEIN; TYROSINE; FYN PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, MOUSE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL BODY; CONTROLLED STUDY; DENDRITIC SPINE; HUMAN; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PSEUDOPHOSPHORYLATION; SYNAPTOSOME; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; C57BL MOUSE; CELL CULTURE; CONFOCAL MICROSCOPY; GENETICS; KNOCKOUT MOUSE; METABOLISM; MISSENSE MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT; TRANSGENIC MOUSE; WESTERN BLOTTING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; DENDRITIC SPINES; EPITOPES; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION, MISSENSE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-FYN; TAU PROTEINS;

EID: 84922576117     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.12.017     Document Type: Article

References (43)

1. Allen B., et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 2002, 22:9340-9351.
2. Ballard C., et al. Alzheimer's disease. Lancet 2011, 377:1019-1031.
3. Bhaskar K., et al. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. Neuropathol. Appl. Neurobiol. 2010, 36:462-477.
4. Bittner T., et al. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 2010, 5:e15477.
5. Boehm J. A 'danse macabre': tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity. Eur. J. Neurosci. 2013, 37:1925-1930.
6. Chabrier M.A., et al. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. Neurobiol. Dis. 2014, 64:107-117.
7. Chen F., et al. Posttranslational modifications of tau - Role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 2004, 5:503-515.
8. Chen Q., et al. Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF. Neurochem. Int. 2012, 60:233-242.
9. Chicurel M.E., Harris K.M. Three-dimensional analysis of the structure and composition of CA3 branched dendritic spines and their synaptic relationships with mossy fiber boutons in the rat hippocampus. J. Comp. Neurol. 1992, 325:169-182.
10. Cochran J.N., et al. The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Res. Bull. 2014, 103:18-28.
11. Deters N., et al. Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Eur. J. Neurosci. 2008, 28:137-147.
12. Fath T., et al. Primary support cultures of hippocampal and substantia nigra neurons. Nat. Protoc. 2009, 4:78-85.
13. Frandemiche M.L., et al. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J. Neurosci. 2014, 34:6084-6097.
14. Götz J., et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J. 1995, 14:1304-1313.
15. Grundke-Iqbal I., et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4913-4917.
16. Hoffmann N.A., et al. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice. Acta Neuropathol. Commun. 2013, 1:82.
17. Hoover B.R., et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010, 68:1067-1081.
18. Hundelt M., et al. Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation. Neurobiol. Aging 2009, 32:991-1006.
19. Ittner L.M., Götz J. Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 2011, 12:65-72.
20. Ittner L.M., et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
21. Kins S., et al. Activation of the ERK and JNK signaling pathways caused by neuron specific inhibition of PP2A in transgenic mice. Am. J. Pathol. 2003, 163:833-843.
22. Kopeikina K.J., et al. Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy. PLoS ONE 2013, 8:e80834.
23. Kramer-Albers E.M., White R. From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell. Mol. Life Sci. 2011, 68:2003-2012.
24. Lacor P.N., et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004, 24:10191-10200.
25. Larson M., et al. The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease. J. Neurosci. 2012, 32:16857-16871a.
26. Lashuel H.A., et al. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 2013, 14:38-48.
27. Lee G., et al. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci. 1998, 111:3167-3177.
28. Lee V.M., et al. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
29. Mairet-Coello G., et al. The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 2013, 78:94-108.
30. Phillips G.R., et al. The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 2001, 32:63-77.
31. Sontag E., et al. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 1996, 17:1201-1207.
32. Sontag J.M., et al. The protein phosphatase PP2A/Balpha binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies. J. Biol. Chem. 2012, 287:14984-14993.
33. Sorra K.E., Harris K.M. Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus 2000, 10:501-511.
34. Stein P.L., et al. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 1992, 70:741-750.
35. Tucker K.L., et al. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 2001, 4:29-37.
36. Usardi A., et al. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J. 2011, 278:2927-2937.
37. Xia D., Götz J. Premature lethality, hyperactivity, and aberrant phosphorylation in transgenic mice expressing a constitutively active form of Fyn. Front. Mol. Neurosci. 2014, 7:40.
38. Xu H., et al. Memory deficits correlate with Tau and spine pathology in P301S MAPT transgenic mice. Neuropathol. Appl. Neurobiol. 2014, 40:833-843.
39. Zamora-Leon S.P., et al. Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2. J. Biol. Chem. 2001, 276:39950-39958.
40. Zempel H., et al. Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 2013, 32:2920-2937.
41. Zempel H., Mandelkow E. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci. 2014, 37:721-732.
42. Zempel H., et al. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 2010, 30:11938-11950.
43. Zhang Z., et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat. Med. 2014, 20:1254-1262.